COVID-19 infection in a patient with multiple sclerosis treated with fingolimod
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received April 2, 2020
- Accepted in final form April 20, 2020
- First Published May 5, 2020.
Author Disclosures
- Mahdi Barzegar, MD,
- Omid Mirmosayyeb, MD,
- Nasim Nehzat, PharmD,
- Reza Sarrafi, MD,
- Farzin Khorvash, MD,
- Amir-Hadi Maghzi, MD and
- Vahid Shaygannejad, MD
- Mahdi Barzegar, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Omid Mirmosayyeb, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Nasim Nehzat, PharmD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Reza Sarrafi, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Farzin Khorvash, MD,
NONE
NONE
NONE
(1) Journal of Research in Medical Sciences, editor, 2020
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Amir-Hadi Maghzi, MD and
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) clinician-scientist development fellowship from the National MS Society and American Brain Foundation, (2) Pilot grant from Women's Brain Initiative, Brigham and Women's Hospital.
NONE
NONE
NONE
NONE
NONE
NONE
- Vahid Shaygannejad, MD
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- From the Department of Neurology (M.B., O.M., R.S., V.S.), School of Medicine, Isfahan University of Medical Sciences; Isfahan Neurosciences Research Center (M.B., O.M., N.N., V.S.), Isfahan University of Medical Sciences; Acquired Immunodeficiency Research Center (F.K.), Isfahan University of Medical Sciences, Iran; and Ann Romney Center for Neurologic Diseases (A.-H.M.), Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
- Correspondence
Dr. Shaygannejad v.shaygannejad{at}gmail.com
Article usage
Cited By...
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Nicole Sur and Dr. Mausaminben Hathidara
► Watch
Related Articles
- No related articles found.
Topics Discussed
Alert Me
Recommended articles
-
Special Editorial
Treating multiple sclerosis and neuromyelitis optica spectrum disorder during the COVID-19 pandemicWallace Brownlee, Dennis Bourdette, Simon Broadley et al.Neurology, April 02, 2020 -
Article
Impact of Disease-Modifying Treatments of Multiple Sclerosis on Anti–SARS-CoV-2 AntibodiesAn Observational StudyKévin Bigaut, Laurent Kremer, Thibaut Fabacher et al.Neurology: Neuroimmunology & Neuroinflammation, July 28, 2021 -
Article
COVID-19 and MS disease-modifying therapiesJoseph R. Berger, Rachel Brandstadter, Amit Bar-Or et al.Neurology: Neuroimmunology & Neuroinflammation, May 15, 2020 -
Article
COVID-19 outcomes in MSObservational study of early experience from NYU Multiple Sclerosis Comprehensive Care CenterErica Parrotta, Ilya Kister, Leigh Charvet et al.Neurology: Neuroimmunology & Neuroinflammation, July 09, 2020